This document discusses testosterone replacement therapy (TRT) and the potential side effect of polycythemia. It notes that longer-acting TRT formulations like intramuscular injections and pellet implants have a higher risk of causing polycythemia compared to shorter-acting options like transdermal gels and patches. The document also recommends screening patients for obstructive sleep apnea prior to starting TRT and managing polycythemia through dose adjustment or phlebotomy if hematocrit is elevated.